| Literature DB >> 28280558 |
Yong Zhi Foo1, Leigh W Simmons1, Gillian Rhodes2.
Abstract
Health has been claimed to play an important role in human sexual selection, especially in terms of mate choice. Our preferences for attractive individuals are said to represent evolved adaptations for finding high-quality, healthy mates. If this is true, then we expect health to predict mating success in humans. We tested this hypothesis using several important physiological indicators of health, including immune function, oxidative stress and semen quality, and self-reported measures of sexual behaviour that contribute to mating success. In contrast to our hypothesis, we did not find a relationship between the physiological measures of health and sexual behaviour. Our results provide little support for claims that health, at least the health measures we used, increases mating success in relatively healthy humans.Entities:
Keywords: health; humans; mating success; sexual selection
Year: 2017 PMID: 28280558 PMCID: PMC5319324 DOI: 10.1098/rsos.160603
Source DB: PubMed Journal: R Soc Open Sci ISSN: 2054-5703 Impact factor: 2.963
Descriptive statistics, including means and s.d.s of the attractiveness, mating success and physiological variables. VAP, average path velocity; VSL, straight line velocity; VCL, velocity along the sperm cells point-to-point track; ALH, lateral amplitude of sperm head movement; BCF, frequency with which the sperm head crosses the average sperm path; STR, straightness of the sperm's path; LIN, linearity of the sperm's path.
| men | women | |||
|---|---|---|---|---|
| mean | mean | |||
| attractiveness | 3.3 | 101 | 3.5 | 79 |
| mating success | ||||
| age at first sexual intercourse | 17.2 ± 2.5 | 86 | 16.9 ± 1.7 | 67 |
| number of sex partners | 5.6 ± 8.4 | 101 | 5.5 ± 7.0 | 77 |
| immune function | ||||
| lysozyme activity | 0.51 ± 0.11 | 98 | 0.51 ± 0.11 | 78 |
| bacterial killing capacity | 7.95 ± 37.78 | 98 | 0.48 ± 41.78 | 78 |
| bacterial suppression capacity | 20.84 ± 16.37 | 98 | 21.96 ± 25.47 | 78 |
| overall bacterial immunity | 29.66 ± 23.64 | 98 | 18.28 ± 15.88 | 78 |
| oxidative stress | ||||
| 8-OHdG | 6.45 ± 3.23 | 98 | 7.67 ± 3.70 | 79 |
| 8-isoprostane | 2.28 ± 1.60 | 101 | 1.91 ± 1.37 | 80 |
| semen quality | ||||
| VAP | 46.93 ± 8.98 | 91 | ||
| VSL | 37.61 ± 7.79 | 91 | ||
| VCL | 69.90 ± 13.51 | 91 | ||
| ALH | 5.32 ± 1.06 | 91 | ||
| BCF | 13.03 ± 1.86 | 91 | ||
| STR | 77.78 ± 9.44 | 91 | ||
| LIN | 54.87 ± 8.92 | 91 | ||
| concentration | 89.72 ± 68.38 | 91 | ||
| % motile sperm | 45.20 ± 17.50 | 91 | ||
Zero-order Pearson product–moment correlations, p-values and Ns between age, mating success, attractiveness and physiological indicators of health. Male results are below the diagonal. Female results are above the diagonal.
| age | age at first sexual intercourse | number of sex partners | attractiveness | immune PC 1 | immune PC 2 | 8-OHdG | 8-isoprostane | semen PC 1 | semen PC 2 | semen PC 3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| age | — | 0.20 | 0.54 | −0.27 | 0.05 | −0.15 | −0.02 | 0.14 | — | — | — |
| 0.10 | 0.00 | 0.01 | 0.64 | 0.20 | 0.86 | 0.22 | |||||
| 67 | 75 | 79 | 77 | 78 | 78 | 79 | |||||
| age at first sexual intercourse | 0.44 | — | −0.27 | 0.02 | 0.17 | 0.00 | −0.06 | 0.10 | — | — | — |
| 0.00 | 0.03 | 0.88 | 0.18 | 0.99 | 0.64 | 0.43 | |||||
| 83 | 63 | 67 | 65 | 66 | 66 | 66 | |||||
| number of sex partners | 0.31 | −0.28 | — | −0.14 | −0.05 | −0.10 | 0.10 | 0.15 | — | — | — |
| 0.00 | 0.01 | 0.24 | 0.70 | 0.40 | 0.39 | 0.19 | |||||
| 97 | 84 | 74 | 72 | 73 | 73 | 74 | |||||
| attractiveness | −0.07 | −0.19 | 0.23 | — | −0.36 | 0.12 | −0.19 | 0.20 | |||
| 0.52 | 0.09 | 0.02 | 0.002 | 0.32 | 0.09 | 0.07 | |||||
| 97 | 85 | 100 | 76 | 77 | 77 | 78 | |||||
| immune PC 1 | 0.08 | 0.12 | −0.07 | −0.16 | — | −0.07 | 0.06 | −0.31 | — | — | — |
| 0.46 | 0.28 | 0.49 | 0.11 | 0.53 | 0.58 | 0.01 | |||||
| 94 | 83 | 97 | 98 | 77 | 76 | 76 | |||||
| immune PC 2 | −0.16 | 0.00 | −0.10 | 0.04 | 0.00 | — | −0.38 | 0.16 | — | — | — |
| 0.13 | 0.99 | 0.35 | 0.72 | 1.00 | 0.00 | 0.17 | |||||
| 94 | 83 | 97 | 98 | 98 | 76 | 77 | |||||
| 8-OHdG | −0.08 | 0.02 | −0.07 | 0.20 | −0.02 | −0.10 | — | −0.12 | — | — | — |
| 0.43 | 0.85 | 0.47 | 0.05 | 0.84 | 0.32 | 0.30 | |||||
| 95 | 82 | 98 | 98 | 95 | 95 | 77 | |||||
| 8-isoprostane | 0.36 | 0.05 | 0.10 | 0.11 | 0.32 | −0.17 | −0.01 | — | — | — | — |
| 0.00 | 0.66 | 0.32 | 0.30 | 0.00 | 0.11 | 0.93 | |||||
| 95 | 83 | 98 | 99 | 96 | 96 | 97 | |||||
| semen PC 1 | −0.17 | −0.07 | −0.05 | 0.01 | 0.20 | −0.03 | −0.01 | −0.10 | — | — | — |
| 0.11 | 0.54 | 0.63 | 0.95 | 0.07 | 0.79 | 0.96 | 0.35 | ||||
| 84 | 76 | 86 | 87 | 84 | 84 | 84 | 85 | ||||
| semen PC 2 | 0.12 | 0.00 | 0.08 | 0.18 | −0.04 | 0.17 | 0.06 | 0.12 | −0.30 | — | — |
| 0.26 | 0.98 | 0.46 | 0.09 | 0.70 | 0.12 | 0.60 | 0.26 | 0.00 | |||
| 82 | 74 | 84 | 85 | 83 | 83 | 82 | 83 | 85 | |||
| semen PC 3 | 0.22 | −0.03 | 0.21 | 0.01 | 0.03 | −0.23 | −0.14 | 0.12 | 0.09 | 0.01 | — |
| 0.04 | 0.81 | 0.05 | 0.95 | 0.81 | 0.03 | 0.20 | 0.27 | 0.43 | 0.91 | ||
| 88 | 78 | 90 | 91 | 88 | 88 | 88 | 89 | 87 | 85 |
Multiple regression models for the physiological indicator predictors of male mating success. Results were based on bootstrapping with 1000 samples and bias-corrected and accelerated 95% CIs.
| B ± s.e. | 95% CI for B | 95% CI | ||||
|---|---|---|---|---|---|---|
| age at first sexual intercourse | ||||||
| age | 0.36 ± 0.09 | 0.01 | [0.10,0.60] | 4.03(59) | 0.46 | [0.25,0.63] |
| immune factor 1 | 0.24 ± 0.24 | 0.33 | [−0.25,0.84] | 1.00(59) | 0.13 | [−0.11,0.36] |
| immune factor 2 | 0.01 ± 0.25 | 0.96 | [−0.42,0.43] | 0.04(59) | 0.01 | [−0.23,0.25] |
| 8-OHdG | 0.07 ± 0.09 | 0.37 | [−0.07,0.23] | 0.81(59) | 0.10 | [−0.14,0.33] |
| 8-isoprostane | −0.38 ± 0.21 | 0.16 | [−0.88,0.25] | −1.82(59) | −0.23 | [−0.44,0.01] |
| semen factor 1 | −0.23 ± 0.26 | 0.34 | [−0.71,0.17] | −0.88(59) | −0.11 | [−0.34,0.13] |
| semen factor 2 | −0.10 ± 0.29 | 0.78 | [−0.73,0.55] | −0.33(59) | −0.04 | [−0.28,0.20] |
| semen factor 3 | −0.10 ± 0.24 | 0.72 | [−0.61,0.47] | −0.41(59) | −0.05 | [−0.29,0.19] |
| number of sex partners | ||||||
| age | 0.62 ± 0.26 | 0.10 | [0.04,1.36] | 2.40(68) | 0.28 | [0.06,0.47] |
| immune factor 1 | −0.63 ± 0.68 | 0.22 | [−1.77,0.36] | −0.92(68) | −0.11 | [−0.33,0.12] |
| immune factor 2 | −0.07 ± 0.62 | 0.91 | [−1.02,0.81] | −0.11(68) | −0.01 | [−0.23,0.21] |
| 8-OHdG | −0.16 ± 0.21 | 0.36 | [−0.50,0.10] | −0.76(68) | −0.09 | [−0.31,0.14] |
| 8-isoprostane | 0.42 ± 0.60 | 0.46 | [−0.62,1.58] | 0.71(68) | 0.09 | [−0.14,0.31] |
| semen factor 1 | 0.17 ± 0.70 | 0.81 | [−1.16,1.38] | 0.24(68) | 0.03 | [−0.20,0.25] |
| semen factor 2 | 0.44 ± 0.73 | 0.61 | [−1.06,2.77] | 0.60(68) | 0.07 | [−0.16,0.29] |
| semen factor 3 | 0.37 ± 0.67 | 0.57 | [−0.82,1.46] | 0.55(68) | 0.07 | [−0.16,0.29] |
Multiple regression models for the physiological indicator predictors of female mating success. Results were based on bootstrapping with 1000 samples and bias-corrected and accelerated 95% CIs.
| B ± s.e. | 95% CI for B | 95% CI | ||||
|---|---|---|---|---|---|---|
| age at first sexual intercourse | ||||||
| age | 0.07 ± 0.05 | 0.15 | [−0.03,0.15] | 1.42(58) | 0.18 | [−0.07,0.41] |
| immune factor 1 | 0.35 ± 0.23 | 0.12 | [−0.05,0.87] | 1.52(58) | 0.20 | [−0.05,0.42] |
| immune factor 2 | 0.00 ± 0.24 | 1.00 | [−0.45,0.54] | −0.01(58) | 0.00 | [−0.25,0.25] |
| 8-OHdG | −0.03 ± 0.23 | 0.87 | [−0.47,0.39] | −0.14(58) | −0.02 | [−0.26,0.23] |
| 8-isoprostane | 0.18 ± 0.20 | 0.33 | [−0.14,0.60] | 0.89(58) | 0.12 | [−0.13,0.36] |
| number of sex partners | ||||||
| age | 0.60 ± 0.13 | 0.00 | [0.37,0.92] | 4.63(64) | 0.50 | [0.30,0.66] |
| immune factor 1 | −0.10 ± 0.56 | 0.85 | [−1.20,1.25] | −0.18(64) | −0.02 | [−0.25,0.22] |
| immune factor 2 | −0.07 ± 0.58 | 0.92 | [−1.21,0.96] | −0.11(64) | −0.01 | [−0.24,0.23] |
| 8-OHdG | 0.64 ± 0.61 | 0.26 | [−0.46,1.68] | 1.06(64) | 0.13 | [−0.11,0.35] |
| 8-isoprostane | 0.29 ± 0.54 | 0.69 | [−0.81,1.83] | 0.54(64) | 0.07 | [−0.17,0.30] |